Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2019 Feb 27

PMID 30804889

Citations 3

Authors

Tal Shomrat

Nir Nesher

Affiliations

Soon will be listed here.

Abstract

Identification of the biological features of autism is essential for designing an efficient treatment and for prevention of the disorder. Though the subject of extensive research, the neurophysiological features of autism remain unclear. One of the proposed biological causes of autism is malfunction of the pineal gland and deficiency of its principal hormone, melatonin. The main function of melatonin is to link and synchronize the body's homeostasis processes to the circadian and seasonal rhythms, and to regulate the sleep-wake cycle. Therefore, pineal dysfunction has been implicated based on the common observation of low melatonin levels and sleep disorders associated with autism. In this perspective, we highlight several recent findings that support the hypothesis of pineal gland/melatonin involvement in autism. Another common symptom of autism is abnormal neuroplasticity, such as cortical overgrowth and dendritic spine dysgenesis. Here, we synthesize recent information and speculate on the possibility that this abnormal neuroplasticity is caused by hyperactivity of endogenous N,N-dimethyltryptamine (DMT). The pineal gland was proposed as the source of DMT in the brain and therefore, our assumption is that besides melatonin deficiency, pineal dysfunction might also play a part in the development of autism through abnormal metabolism of DMT. We hope that this manuscript will encourage future research of the DMT hypothesis and reexamination of several observations that were previously attributed to other factors, to see if they could be related to pineal gland/melatonin malfunction. Such research could contribute to the development of autism treatment by exogenous melatonin and monitored light exposure.

Citing Articles

Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management.

Megha K, Arathi A, Shikha S, Alka R, Ramya P, Mohanan P Mol Neurobiol. 2024; 61(8):5541-5571.

PMID: 38206471 DOI: 10.1007/s12035-024-03915-0.

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.

Mastinu A, Anyanwu M, Carone M, Abate G, Bonini S, Peron G Int J Mol Sci. 2023; 24(2).

PMID: 36674849 PMC: 9865175. DOI: 10.3390/ijms24021329.

Neonatal irritable sleep-wake rhythm as a predictor of autism spectrum disorders.

Miike T, Toyoura M, Tonooka S, Konishi Y, Oniki K, Saruwatari J Neurobiol Sleep Circadian Rhythms. 2020; 9:100053.

PMID: 33364522 PMC: 7752733. DOI: 10.1016/j.nbscr.2020.100053.

References

Nakamura Y, Tamura H, Kashida S, Takayama H, Yamagata Y, Karube A . Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001; 30(1):29-33. DOI: 10.1034/j.1600-079x.2001.300104.x. View

Craven C . Pineal germinoma and psychosis. J Am Acad Child Adolesc Psychiatry. 2001; 40(1):6. DOI: 10.1097/00004583-200101000-00008. View

Miyazawa T, Fukui S, Otani N, Tsuzuki N, Katoh H, Ishihara S . Peduncular hallucinosis due to a pineal meningioma. Case report. J Neurosurg. 2001; 95(3):500-2. DOI: 10.3171/jns.2001.95.3.0500. View

Tauman R, Zisapel N, Laudon M, Nehama H, Sivan Y . Melatonin production in infants. Pediatr Neurol. 2002; 26(5):379-82. DOI: 10.1016/s0887-8994(01)00417-9. View

Hebert M, Martin S, Lee C, Eastman C . The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res. 2002; 33(4):198-203. PMC: 3925650. DOI: 10.1034/j.1600-079x.2002.01885.x. View

Ashwood P, Van de Water J . Is autism an autoimmune disease?. Autoimmun Rev. 2004; 3(7-8):557-62. DOI: 10.1016/j.autrev.2004.07.036. View

Irmak M, Topal T, Oter S . Melatonin seems to be a mediator that transfers the environmental stimuli to oocytes for inheritance of adaptive changes through epigenetic inheritance system. Med Hypotheses. 2005; 64(6):1138-43. DOI: 10.1016/j.mehy.2004.12.014. View

Chauhan A, Chauhan V . Oxidative stress in autism. Pathophysiology. 2006; 13(3):171-81. DOI: 10.1016/j.pathophys.2006.05.007. View

Mukaddes N, Kilincaslan A, Kucukyazici G, Sevketoglu T, Tuncer S . Autism in visually impaired individuals. Psychiatry Clin Neurosci. 2007; 61(1):39-44. DOI: 10.1111/j.1440-1819.2007.01608.x. View

10.

Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsater H . Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2007; 13(1):90-8. PMC: 2199264. DOI: 10.1038/sj.mp.4002016. View

11.

Davis L, Hazlett H, Librant A, Nopoulos P, Sheffield V, Piven J . Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(7):1145-51. PMC: 2752707. DOI: 10.1002/ajmg.b.30738. View

12.

Higuchi S, Ishibashi K, Aritake S, Enomoto M, Hida A, Tamura M . Inter-individual difference in pupil size correlates to suppression of melatonin by exposure to light. Neurosci Lett. 2008; 440(1):23-6. DOI: 10.1016/j.neulet.2008.05.037. View

13.

Anderson C, Colombo J . Larger tonic pupil size in young children with autism spectrum disorder. Dev Psychobiol. 2008; 51(2):207-11. PMC: 3744086. DOI: 10.1002/dev.20352. View

14.

Fontanilla D, Johannessen M, Hajipour A, Cozzi N, Jackson M, Ruoho A . The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009; 323(5916):934-7. PMC: 2947205. DOI: 10.1126/science.1166127. View

15.

Hu V, Sarachana T, Kim K, Nguyen A, Kulkarni S, Steinberg M . Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009; 2(2):78-97. PMC: 2737477. DOI: 10.1002/aur.73. View

16.

Baron-Cohen S, Ashwin E, Ashwin C, Tavassoli T, Chakrabarti B . Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos Trans R Soc Lond B Biol Sci. 2009; 364(1522):1377-83. PMC: 2677592. DOI: 10.1098/rstb.2008.0337. View

17.

Jang S, Liu X, Pradoldej S, Tosini G, Chang Q, Iuvone P . N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci U S A. 2010; 107(8):3876-81. PMC: 2840510. DOI: 10.1073/pnas.0912531107. View

18.

Emanuele E, Colombo R, Martinelli V, Brondino N, Marini M, Boso M . Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia. Neuro Endocrinol Lett. 2010; 31(1):117-21. View

19.

Sanchez-Barcelo E, Mediavilla M, Tan D, Reiter R . Clinical uses of melatonin: evaluation of human trials. Curr Med Chem. 2010; 17(19):2070-95. DOI: 10.2174/092986710791233689. View

20.

Ratajczak H . Theoretical aspects of autism: biomarkers--a review. J Immunotoxicol. 2011; 8(1):80-94. DOI: 10.3109/1547691X.2010.538749. View